These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
206 related articles for article (PubMed ID: 23236531)
21. Drug resistance in leprosy: lessons from past and future perspective. Gupta UD; Katoch VM Indian J Lepr; 1999; 71(4):451-63. PubMed ID: 10804973 [TBL] [Abstract][Full Text] [Related]
22. Multidrug therapy (MDT) and leprosy control. Noordeen SK Indian J Lepr; 1990; 62(4):448-58. PubMed ID: 2086680 [No Abstract] [Full Text] [Related]
23. Is drug-resistant Mycobacterium leprae a real cause for concern?: First approach to molecular monitoring of multibacillary Colombian patients with and without previous leprosy treatment. Guerrero MI; Colorado CL; Torres JF; León CI Biomedica; 2014 Apr; 34 Suppl 1():137-47. PubMed ID: 24968045 [TBL] [Abstract][Full Text] [Related]
24. Clofazimine-resistant M. leprae. Levy L Int J Lepr Other Mycobact Dis; 1986 Mar; 54(1):137-40. PubMed ID: 3519801 [No Abstract] [Full Text] [Related]
25. Combined clofazimine- and dapsone-resistant leprosy. A case report. Kar HK; Bhatia VN; Harikrishnan S Int J Lepr Other Mycobact Dis; 1986 Sep; 54(3):389-91. PubMed ID: 3528345 [TBL] [Abstract][Full Text] [Related]
26. [Multi-drug resistant Mycobacterium leprae from patients with leprosy]. Maeda S Nihon Hansenbyo Gakkai Zasshi; 2004 Sep; 73(3):227-33. PubMed ID: 15508725 [TBL] [Abstract][Full Text] [Related]
27. Viability of Myco. leprae in the skin and bone marrow of patients with lepromatous leprosy while on dapsone or lamprene. Karat AB Lepr Rev; 1975 Jun; 46(2 Suppl):69-72. PubMed ID: 1100966 [No Abstract] [Full Text] [Related]
28. Drug susceptibility testing of Mycobacterium leprae in the BACTEC 460 system. Franzblau SG Antimicrob Agents Chemother; 1989 Dec; 33(12):2115-7. PubMed ID: 2694952 [TBL] [Abstract][Full Text] [Related]
29. Activity of ascorbic acid in inhibiting the multiplication of M. leprae in the mouse foot pad. Hastings RC; Richard V; Christy SA; Morales MJ Int J Lepr Other Mycobact Dis; 1976; 44(4):427-30. PubMed ID: 798727 [TBL] [Abstract][Full Text] [Related]
30. [Basic evaluation for new antimicrobial susceptibility testing of Mycobacterium leprae by bioluminescence assay (ATP method)]. Yamazaki T; Gidoh M; Matsuoka M Nihon Hansenbyo Gakkai Zasshi; 2006 Sep; 75(3):227-37. PubMed ID: 17037377 [TBL] [Abstract][Full Text] [Related]
31. Clinical pilot study: Clarithromycin efficacy in multibacillary leprosy therapy. Gunawan H; Sasmojo M; Putri HE; Avriyanti E; Hindritiani R; Suwarsa O Int J Mycobacteriol; 2018; 7(2):152-155. PubMed ID: 29900892 [TBL] [Abstract][Full Text] [Related]
32. Effect of rifampin, clofazimine, and B1912 on the viability of Mycobacterium leprae in established mouse footpad infection. Holmes IB; Banerjee DK; Hilson GR Proc Soc Exp Biol Med; 1976 Apr; 151(4):637-41. PubMed ID: 772686 [TBL] [Abstract][Full Text] [Related]
33. [Drug resistance of Mycobacterium leprae]. Pattyn SR Acta Leprol; 1986; 4(3):279-87. PubMed ID: 3551466 [No Abstract] [Full Text] [Related]
34. An attempt to induce a histological ENL symptom in M. leprae infected nude mice. Subowo Nihon Rai Gakkai Zasshi; 1986; 55(4):173-85. PubMed ID: 3323158 [No Abstract] [Full Text] [Related]
35. Comparative in vitro activities of rifamycin analogues against Mycobacterium leprae. Dhople AM Indian J Lepr; 1997; 69(4):377-84. PubMed ID: 9474513 [TBL] [Abstract][Full Text] [Related]
36. The frequency of drug resistance mutations in Mycobacterium leprae isolates in untreated and relapsed leprosy patients from Myanmar, Indonesia and the Philippines. Matsuoka M; Budiawan T; Aye KS; Kyaw K; Tan EV; Cruz ED; Gelber R; Saunderson P; Balagon V; Pannikar V Lepr Rev; 2007 Dec; 78(4):343-52. PubMed ID: 18309708 [TBL] [Abstract][Full Text] [Related]
37. Application of ATP assay for in vitro drug screening testing against human derived M. leprae. Katoch VM; Katoch K; Shivannavar CT; Sharma VD; Patil MA; Bharadwaj VP Indian J Lepr; 1989 Jul; 61(3):333-44. PubMed ID: 2671179 [TBL] [Abstract][Full Text] [Related]
38. The chemotherapy of leprosy. Part 1. Ellard GA Int J Lepr Other Mycobact Dis; 1990 Dec; 58(4):704-16. PubMed ID: 2280120 [No Abstract] [Full Text] [Related]
39. In vitro and in vivo effects of N-methyl-3,5-dichloro-benzylamine hydrochloride on Mycobacterium leprae. Dhople AM; Strong LC; Meindl W; Schoenenberger H; Gardner GD Arzneimittelforschung; 1991 Mar; 41(3):253-6. PubMed ID: 1867663 [TBL] [Abstract][Full Text] [Related]
40. Mycobacterium leprae promotes triacylglycerol de novo synthesis through induction of GPAT3 expression in human premonocytic THP-1 cells. Tanigawa K; Hayashi Y; Hama K; Yamashita A; Yokoyama K; Luo Y; Kawashima A; Maeda Y; Nakamura Y; Harada A; Kiriya M; Karasawa K; Suzuki K PLoS One; 2021; 16(3):e0249184. PubMed ID: 33770127 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]